![Mark Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Chen
Direktor/Vorstandsmitglied bei
GLOBAL CORD BLOOD CORPORATION
Profil
Mr. Mark D.
Chen is an Independent Non-Executive Director at MEGAIN Holding (Cayman) Co. Ltd., an Independent Non-Executive Director at Global Cord Blood Corp.
and a Managing Partner at Pantheon Pacific Capital Management Ltd. He is on the Board of Directors at MEGAIN Holding (Cayman) Co. Ltd. and Global Cord Blood Corp.
Mr. Chen was previously employed as an Independent Director by Skystar Bio-Pharmaceutical Co., a Chairman, President & Chief Executive Officer by Pantheon China Acquisition Corp., a Managing Director by Ecc Advisors LLC, a Managing Director by Easton Capital Investment Group, and a Senior Executive Officer by Suredata, Inc. He also served on the board at Sonics, Inc. He received his undergraduate degree from Shanghai Jiao Tong University, a graduate degree from The Pennsylvania State University and an MBA from Columbia Business School.
Aktive Positionen von Mark Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| GLOBAL CORD BLOOD CORPORATION | Direktor/Vorstandsmitglied | 01.01.2009 |
| MEGAIN HOLDING (CAYMAN) CO., LTD. | Direktor/Vorstandsmitglied | 01.02.2021 |
Pantheon Pacific Capital Management Ltd.
 Pantheon Pacific Capital Management Ltd. Investment ManagersFinance Operates as a private equity investment management company | Corporate Officer/Principal | 01.01.2009 |
Ehemalige bekannte Positionen von Mark Chen
| Unternehmen | Position | Ende |
|---|---|---|
Pantheon China Acquisition Corp.
 Pantheon China Acquisition Corp. Financial ConglomeratesFinance Seeks to invest in, merge with, or acquire a company based in the People's Republic of China | Vorstandsvorsitzender | 05.08.2009 |
Easton Capital Investment Group
 Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Private Equity Investor | 12.03.2006 |
Ecc Advisors LLC
 Ecc Advisors LLC Investment ManagersFinance Provides investment advice | Vorstandsvorsitzender | 01.01.2006 |
Suredata, Inc. | Gründer | - |
| SKYSTAR BIO-PHARMACEUTICAL COMPANY | Direktor/Vorstandsmitglied | - |
Ausbildung von Mark Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Pantheon China Acquisition Corp.
Pantheon China Acquisition Corp. Financial ConglomeratesFinance Seeks to invest in, merge with, or acquire a company based in the People's Republic of China | Finance |
Global Cord Blood Corp.
 Global Cord Blood Corp. Medical/Nursing ServicesHealth Services Provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services | Health Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonics, Inc.
 Sonics, Inc. Information Technology ServicesTechnology Services Provides system Internet protocol services | Technology Services |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Finance |
Skystar Bio-Pharmaceutical Co.
 Skystar Bio-Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Manufactures veterinary drugs, fodder additive, and microorganism preparation products | Health Technology |
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suredata, Inc. | |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecc Advisors LLC
Ecc Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
Pantheon Pacific Capital Management Ltd.
Pantheon Pacific Capital Management Ltd. Investment ManagersFinance Operates as a private equity investment management company | Finance |
MEGAIN Holding (Cayman) Co. Ltd.
 MEGAIN Holding (Cayman) Co. Ltd. SemiconductorsElectronic Technology Manufactures and sells consumable chips and cartridges | Electronic Technology |
